The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genomic immunotherapy (IO) biomarkers detected on comprehensive genomic profiling (CGP) of tissue and circulating tumor DNA (ctDNA).
 
Takayuki Yoshino
Honoraria - Bayer Yakuhin; Chugai Pharma; Lilly Japan; Merck; Takeda
Research Funding - Amgen (Inst); Chugai Pharma (Inst); DAIICHI SANKYO COMPANY, LIMITED (Inst); MSD (Inst); Ono Pharmaceutical (Inst); PAREXEL International Inc. (Inst); Sanofi (Inst); Sumitomo Dainippon (Inst); Taiho Pharmaceutical (Inst)
 
Hanna Tukachinsky
Employment - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
 
Jessica Kim Lee
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
 
Ethan Sokol
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
 
Dean C. Pavlick
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
 
Aparna Aiyer
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
 
David Fabrizio
Employment - Foundation Medicine
Stock and Other Ownership Interests - Bristol-Myers Squibb; Foundation Medicine; Juno Therapeutics; Seagen
 
Jeffrey Michael Venstrom
Employment - Foundation Medicine; Genentech
Leadership - Genentech
Stock and Other Ownership Interests - Genentech
Research Funding - Foundation Medicine; Genentech/Roche
Travel, Accommodations, Expenses - Genentech; Genentech
 
Saori Mishima
No Relationships to Disclose
 
Yoshiaki Nakamura
Research Funding - Chugai Pharma (Inst); Genomedia (Inst); Guardant Health (Inst); Taiho Pharmaceutical (Inst)
 
Geoffrey R. Oxnard
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
Honoraria - Foundation Medicine; Guardant Health
Consulting or Advisory Role - Abbvie; AstraZeneca; DropWorks; GRAIL; Illumina; Inivata; Janssen; LOXO; Merck; Sysmex; Takeda
Patents, Royalties, Other Intellectual Property - DFCI has a patent pending titled "Non-invasive blood-based monitoring of genomic alterations in cancer", on which I am a co-author. (Inst)